GBD 2016 Alcohol and Drug Use Collaborators. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 [published correction appears in Lancet Psychiatry. 2019 Jan;6:e2]. Lancet Psychiatry. 2018;5:987–1012. https://doi.org/10.1016/S2215-0366(18)30337-7.

Lucey MR. Alcohol-associated cirrhosis. Clin Liver Dis. 2019;23:115–126. https://doi.org/10.1016/j.cld.2018.09.013.

Article  PubMed  Google Scholar 

Lee BP, Vittinghoff E, Dodge JL, Cullaro G, Terrault NA. National trends and long-term outcomes of liver transplant for alcohol-associated liver disease in the United States [published correction appears in JAMA Intern Med. 2019 Dec 1;179:1739]. JAMA Intern Med. 2019;179:340–348. https://doi.org/10.1001/jamainternmed.2018.6536.

Erard-Poinsot D, Dharancy S, Hilleret MN et al. Natural history of recurrent alcohol-related cirrhosis after liver transplantation: fast and furious. Liver Transplant. 2020;26:25–33. https://doi.org/10.1002/lt.25647.

Article  Google Scholar 

Twohig PA, Khoury N, Zoucha KA, Olivera MA. Addiction prescription: a bridge between addiction medicine and digestive diseases. Dig Dis Sci. 2023;68:4–6. https://doi.org/10.1007/s10620-022-07736-w.

Article  PubMed  Google Scholar 

SAMHSA, Center for Behavioral Health Statistics and Quality. National Survey on Drug Use and Health. SAMHSA, Center for Behavioral Health Statistics and Quality, 2022 and 2023.

Cohen E, Feinn R, Arias A, Kranzler HR. Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2007;86:214–221. https://doi.org/10.1016/j.drugalcdep.2006.06.008.

Article  PubMed  Google Scholar 

Probst C, Manthey J, Martinez A, Rehm J. Alcohol use disorder severity and reported reasons not to seek treatment: a cross-sectional study in European primary care practices. Subst Abuse Treat Prev Policy. 2015;10:32. Published 2015 Aug 12. https://doi.org/10.1186/s13011-015-0028-z.

Williams EC, Achtmeyer CE, Young JP et al. Barriers to and facilitators of alcohol use disorder pharmacotherapy in primary care: a qualitative study in five VA clinics. J Gen Intern Med. 2018;33:258–267. https://doi.org/10.1007/s11606-017-4202-z.

Article  PubMed  Google Scholar 

Kelly JF, Wakeman SE, Saitz R. Stop talking ‘dirty’: clinicians, language, and quality of care for the leading cause of preventable death in the United States. Am J Med. 2015;128:8–9. https://doi.org/10.1016/j.amjmed.2014.07.043.

Article  PubMed  Google Scholar 

Kelly JF, Westerhoff CM. Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms. Int J Drug Policy. 2010;21:202–207. https://doi.org/10.1016/j.drugpo.2009.10.010.

Article  PubMed  Google Scholar 

Wolk CB, Doubeni CA, Klusaritz HA, Bilger A, Paterson E, Oslin DW. Perspectives and practice in the identification and treatment of opioid use, alcohol use, and depressive disorders. Psychiatry Serv. 2019;70:940–943. https://doi.org/10.1176/appi.ps.201800378.

Article  Google Scholar 

Mark TL, Kranzler HR, Song X. Understanding US addiction physicians’ low rate of naltrexone prescription. Drug Alcohol Depend. 2003;71:219–228. https://doi.org/10.1016/s0376-8716(03)00134-0.

Article  PubMed  Google Scholar 

Hyland K, Hammarberg A, Andreasson S, Jirwe M. Treatment of alcohol dependence in Swedish primary care: perceptions among general practitioners. Scand J Prim Health Care. 2021;39:247–256. https://doi.org/10.1080/02813432.2021.1922834.

Article  PubMed  PubMed Central  Google Scholar 

Harris AHS, Ellerbe L, Reeder RN et al. Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers. Psychol Serv. 2013;10:410–419. https://doi.org/10.1037/a0030949.

Article  PubMed  Google Scholar 

McCormick KA, Cochran NE, Back AL, Merrill JO, Williams EC, Bradley KA. How primary care providers talk to patients about alcohol: a qualitative study. J Gen Intern Med. 2006;21:966–972. https://doi.org/10.1111/j.1525-1497.2006.00490.x.

Article  PubMed  PubMed Central  Google Scholar 

Im GY, Mellinger JL, Winters A et al. Provider attitudes and practices for alcohol screening, treatment, and education in patients with liver disease: a survey from the American Association for the Study of Liver Diseases Alcohol-Associated Liver Disease Special Interest Group. Clin Gastroenterol Hepatol. 2021;19:2407-2416.e8. https://doi.org/10.1016/j.cgh.2020.10.026.

Article  PubMed  Google Scholar 

Spithoff S, Kahan M. Primary care management of alcohol use disorder and at-risk drinking: Part 2: counsel, prescribe, connect. Can Fam Physician. 2015;61:515–521.

PubMed  PubMed Central  Google Scholar 

Wallhed Finn S, Hammarberg A, Andreasson S. Treatment for alcohol dependence in primary care compared to outpatient specialist treatment—a randomized controlled trial. Alcohol Alcohol. 2018;53:376–385. https://doi.org/10.1093/alcalc/agx126.

Article  PubMed  Google Scholar 

Anton RF, O’Malley SS, Ciraulo DA et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006;295:2003–2017. https://doi.org/10.1001/jama.295.17.2003.

Article  PubMed  Google Scholar 

Amaro H, Sanchez M, Bautista T, Cox R. Social vulnerabilities for substance use: stressors, socially toxic environments, and discrimination and racism. Neuropharmacology. 2021;188:108518. https://doi.org/10.1016/j.neuropharm.2021.108518.

Article  PubMed  PubMed Central  Google Scholar 

Probst C, Roerecke M, Behrendt S, Rehm J. Socioeconomic differences in alcohol-attributable mortality compared with all-cause mortality: a systematic review and meta-analysis. Int J Epidemiol. 2014;43:1314–1327. https://doi.org/10.1093/ije/dyu043.

Article  PubMed  PubMed Central  Google Scholar 

Haque LY, Jakab S, Deng Y, Ciarleglio MM, Tetrault JM. Substance use disorders in recently hospitalized patients with cirrhosis. J Addict Med. 2020;14:e337–e343. https://doi.org/10.1097/ADM.0000000000000677.

Article  PubMed  PubMed Central  Google Scholar 

Rogal S, Youk A, Zhang H et al. Impact of alcohol use disorder treatment on clinical outcomes among patients with cirrhosis. Hepatology. 2020;71:2080–2092. https://doi.org/10.1002/hep.31042.

Article  PubMed  Google Scholar 

Mellinger JL, Scott Winder G, DeJonckheere M et al. Misconceptions, preferences and barriers to alcohol use disorder treatment in alcohol-related cirrhosis. J Subst Abuse Treat. 2018;91:20–27. https://doi.org/10.1016/j.jsat.2018.05.003.

Article  PubMed  Google Scholar 

Altamirano J, López-Pelayo H, Michelena J et al. Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: prediction and impact on long-term survival. Hepatology. 2017;66:1842–1853. https://doi.org/10.1002/hep.29338.

Article  PubMed  Google Scholar 

Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2020;71:306–333. https://doi.org/10.1002/hep.30866.

Article  PubMed  Google Scholar